UBS AM
AXNX

UBS AM’s Axonics, Inc. Common Stock AXNX Stock Holding History

UBS AM’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-125,655
Closed -$8.75M – 2782
2024
Q3 		$8.75M Sell
125,655
-13,576
-10% -$931K ﹤0.01% 1298
2024
Q2 		$9.36M Buy
139,231
+78,279
+128% +$5.27M ﹤0.01% 1165
2024
Q1 		$4.2M Hold
60,952
– – ﹤0.01% 1333
2023
Q4 		$3.79M Buy
60,952
+8,249
+16% +$461K ﹤0.01% 1387
2023
Q3 		$2.96M Buy
52,703
+5,951
+13% +$335K ﹤0.01% 1438
2023
Q2 		$2.55M Hold
46,752
– – ﹤0.01% 1538
2023
Q1 		$2.55M Buy
46,752
+5,428
+13% +$317K ﹤0.01% 1538
2022
Q4 		$2.58M Buy
41,324
+653
+2% +$43.3K ﹤0.01% 1418
2022
Q3 		$2.86M Sell
40,671
-10,807
-21% -$745K ﹤0.01% 1413
2022
Q2 		$2.92M Buy
51,478
+2,079
+4% +$114K ﹤0.01% 1448
2022
Q1 		$3.09M Buy
49,399
+7,608
+18% +$410K ﹤0.01% 1570
2021
Q4 		$2.34M Buy
41,791
+5,311
+15% +$325K ﹤0.01% 1795
2021
Q3 		$2.37M Buy
36,480
+5,229
+17% +$357K ﹤0.01% 1758
2021
Q2 		$1.98M Buy
31,251
+9,841
+46% +$581K ﹤0.01% 1851
2021
Q1 		$1.28M Buy
21,410
+1,500
+8% +$81.6K ﹤0.01% 1963
2020
Q4 		$994K Sell
19,910
-4,800
-19% -$225K ﹤0.01% 1994
2020
Q3 		$1.26M Buy
24,710
+5,936
+32% +$248K ﹤0.01% 1751
2020
Q2 		$659K Buy
18,774
+10,074
+116% +$347K ﹤0.01% 1992
2020
Q1 		$221K Buy
+8,700
New +$259K ﹤0.01% 2244

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

UBS AM's AXNX Position: Q4 2024 in Review

UBS AM sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 125,655 shares — an estimated $8.75M sold.

UBS AM first reported a position in AXNX in Q1 2020 and held it in 19 quarters. The position peaked at $9.36M in Q2 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • UBS AM reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • UBS AM sold 125,655 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $8.75M.
  • UBS AM first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
  • UBS AM's Axonics, Inc. Common Stock position peaked at $9.36M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on UBS AM's 13F filing for Q4 2024, filed 14 Feb 2025.